Dudediligence.

Alumis Inc

ALMSNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$140,000

1 notice · 5,000 sh

Oct 2025 to Oct 2026

Reported ·

$51.0M

0 sales · 36 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-07-06: SANAMPREET PANGALI, Form 1442025-11-13: AKKARAJU SRINIVAS, bought2025-11-17: Tananbaum James B., bought2025-11-17: Foresite Capital Fund V, L.P., bought2025-11-17: Foresite Labs, LLC, bought2025-11-17: AKKARAJU SRINIVAS, bought2025-11-20: AKKARAJU SRINIVAS, bought2025-11-21: Foresite Labs, LLC, bought2025-11-21: Tananbaum James B., bought2025-11-21: Foresite Capital Fund V, L.P., bought2025-11-26: AKKARAJU SRINIVAS, bought2025-12-02: AKKARAJU SRINIVAS, bought2025-12-05: AKKARAJU SRINIVAS, bought2026-01-08: Tananbaum James B., bought2026-01-08: Foresite Capital Fund V, L.P., bought2026-01-08: Foresite Labs, LLC, bought2026-01-09: AKKARAJU SRINIVAS, bought
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-07-06SANAMPREET PANGALI, Chief Legal Officer$140,000
5,000 shno plan dateForm 4s on file end Jun 23144 ↗